{"hands_on_practices": [{"introduction": "A drug's journey from administration to effect begins with its binding to specific molecular targets. This practice [@problem_id:4811976] grounds our understanding of addiction in fundamental pharmacodynamics, exploring the relationship between drug concentration, receptor affinity, and receptor occupancy. By calculating the plasma concentrations required to achieve behavioral thresholds, you will gain a quantitative appreciation for how a drug's pharmacokinetic properties and its molecular interaction with a receptor like the $\\mu$-opioid receptor determine its therapeutic and addictive potential.", "problem": "A simplified pathophysiological model of opioid effects assumes that behavioral outcomes emerge when the fraction of occupied $\\mu$-opioid receptors (MOR) in relevant circuits exceeds fixed thresholds. Let the analgesia threshold be an occupancy of $\\theta_{\\mathrm{an}} = 0.30$ in the spinal cord and the euphoria threshold be $\\theta_{\\mathrm{eu}} = 0.60$ in the nucleus accumbens. Consider two ligands that bind the same MOR site with different affinities and distribution properties:\n\n- Ligand A has dissociation constant $K_{D,A} = 5\\,\\mathrm{nM}$, plasma unbound fraction $f_{u,A} = 0.10$, and unbound brain-to-plasma partition coefficient $K_{p,uu,A} = 1.50$.\n- Ligand B has dissociation constant $K_{D,B} = 40\\,\\mathrm{nM}$, plasma unbound fraction $f_{u,B} = 0.50$, and unbound brain-to-plasma partition coefficient $K_{p,uu,B} = 0.80$.\n\nAssume rapid equilibrium binding, a single binding site, negligible receptor reserve, and that the free extracellular ligand concentration in brain is related to the total plasma concentration by $C_{\\mathrm{brain,free}} = f_{u}\\,K_{p,uu}\\,C_{\\mathrm{plasma,total}}$. Starting from the equilibrium binding definition of the dissociation constant and the law of mass action, derive the receptor occupancy as a function of the free ligand concentration and affinity, determine the minimal $C_{\\mathrm{plasma,total}}$ required for each ligand to reach the euphoria threshold $\\theta_{\\mathrm{eu}}$, and then compute the ratio of these minimal plasma total concentrations for Ligand B relative to Ligand A. Express the final ratio as a dimensionless number, rounded to three significant figures. You may assume that if the euphoria threshold is reached, the analgesia threshold is also reached under the same conditions, but you must justify this within your derivation.", "solution": "The fundamental basis is the law of mass action and the definition of the dissociation constant for a single-site reversible binding interaction. For receptor $R$ and ligand $L$, the equilibrium is\n$$\nR + L \\leftrightarrow RL,\n$$\nwith dissociation constant\n$$\nK_{D} = \\frac{[R][L]}{[RL]}.\n$$\nLet the total receptor concentration be $[R]_{T} = [R] + [RL]$. The fractional occupancy is defined as\n$$\n\\theta = \\frac{[RL]}{[R]_{T}}.\n$$\nUsing $[R] = [R]_{T} - [RL]$ in the definition of $K_{D}$,\n$$\nK_{D} = \\frac{([R]_{T} - [RL])[L]}{[RL]} = \\frac{[R]_{T}[L]}{[RL]} - [L].\n$$\nSolving for $\\theta$ via $[RL] = \\theta [R]_{T}$ and substituting yields\n$$\nK_{D} = \\frac{[R]_{T}[L]}{\\theta [R]_{T}} - [L] = \\frac{[L]}{\\theta} - [L] = [L]\\left(\\frac{1}{\\theta} - 1\\right) = [L]\\frac{1 - \\theta}{\\theta}.\n$$\nSolving for $\\theta$ as a function of the free ligand concentration $[L]$ and affinity $K_{D}$ gives\n$$\n\\theta = \\frac{[L]}{[L] + K_{D}}.\n$$\nGiven a target occupancy $\\theta^{*}$, the free ligand concentration required is found by inverting:\n$$\n\\theta^{*} = \\frac{[L]}{[L] + K_{D}} \\quad \\Rightarrow \\quad [L] = \\frac{\\theta^{*}}{1 - \\theta^{*}}\\,K_{D}.\n$$\nWe apply this to the euphoria threshold $\\theta_{\\mathrm{eu}} = 0.60$. Thus the required free extracellular brain concentration for euphoria for any ligand with dissociation constant $K_{D}$ is\n$$\nC_{\\mathrm{brain,free,eu}} = \\frac{0.60}{1 - 0.60}\\,K_{D} = \\frac{0.60}{0.40}\\,K_{D} = 1.5\\,K_{D}.\n$$\nFor Ligand A ($K_{D,A} = 5\\,\\mathrm{nM}$),\n$$\nC_{\\mathrm{brain,free,eu},A} = 1.5 \\times 5\\,\\mathrm{nM} = 7.5\\,\\mathrm{nM}.\n$$\nFor Ligand B ($K_{D,B} = 40\\,\\mathrm{nM}$),\n$$\nC_{\\mathrm{brain,free,eu},B} = 1.5 \\times 40\\,\\mathrm{nM} = 60\\,\\mathrm{nM}.\n$$\nThe relationship between the free brain concentration and the total plasma concentration is\n$$\nC_{\\mathrm{brain,free}} = f_{u}\\,K_{p,uu}\\,C_{\\mathrm{plasma,total}} \\quad \\Rightarrow \\quad C_{\\mathrm{plasma,total}} = \\frac{C_{\\mathrm{brain,free}}}{f_{u}\\,K_{p,uu}}.\n$$\nTherefore, the minimal plasma total concentration to reach $\\theta_{\\mathrm{eu}}$ is\n$$\nC_{\\mathrm{plasma,total,min}} = \\frac{C_{\\mathrm{brain,free,eu}}}{f_{u}\\,K_{p,uu}}.\n$$\nCompute for each ligand:\n\nFor Ligand A, with $f_{u,A} = 0.10$ and $K_{p,uu,A} = 1.50$,\n$$\nC_{\\mathrm{plasma,total,min},A} = \\frac{7.5\\,\\mathrm{nM}}{0.10 \\times 1.50} = \\frac{7.5}{0.15}\\,\\mathrm{nM} = 50\\,\\mathrm{nM}.\n$$\n\nFor Ligand B, with $f_{u,B} = 0.50$ and $K_{p,uu,B} = 0.80$,\n$$\nC_{\\mathrm{plasma,total,min},B} = \\frac{60\\,\\mathrm{nM}}{0.50 \\times 0.80} = \\frac{60}{0.40}\\,\\mathrm{nM} = 150\\,\\mathrm{nM}.\n$$\n\nThe requested ratio of minimal plasma total concentrations for Ligand B relative to Ligand A is\n$$\n\\frac{C_{\\mathrm{plasma,total,min},B}}{C_{\\mathrm{plasma,total,min},A}} = \\frac{150}{50} = 3.\n$$\n\nFinally, we justify that achieving the euphoria threshold implies achieving the analgesia threshold. The occupancy function $\\theta([L]) = \\frac{[L]}{[L] + K_{D}}$ is strictly increasing in $[L]$ for $[L] \\geq 0$ and fixed $K_{D} > 0$. If $\\theta_{\\mathrm{eu}} = 0.60$ is reached at some $[L]_{\\mathrm{eu}}$, then for the same ligand and receptor, $\\theta([L]_{\\mathrm{eu}}) = 0.60 > 0.30 = \\theta_{\\mathrm{an}}$. Hence the analgesia threshold is met whenever the euphoria threshold is met.\n\nRounding the ratio to three significant figures yields $3.00$.", "answer": "$$\\boxed{3.00}$$", "id": "4811976"}, {"introduction": "Addiction is increasingly understood as a disorder of maladaptive learning, where drugs of abuse hijack the brain's natural reward-learning mechanisms. At the heart of this process is the phasic firing of dopamine neurons, which is thought to encode a reward prediction error (RPE) â€” the difference between expected and received reward. This exercise [@problem_id:4502357] uses the temporal difference (TD) reinforcement learning model to simulate this process, allowing you to calculate the RPE signal under various conditions, including unexpected rewards and reward omissions, which are critical events in the development of compulsive drug-seeking behavior.", "problem": "A central hypothesis in addiction neurobiology is that phasic firing of midbrain dopaminergic neurons encodes a reward prediction error. In computational terms, under Reinforcement Learning (RL), the Temporal Difference (TD) error is defined as the discrepancy between obtained and expected value. Consider a Pavlovian conditioning experiment in which the reward consumption event is terminal within each trial. Under this terminal-event assumption, the next-state value is zero, so the TD error reduces to the difference between obtained reward and the current predicted value at the time of consumption.\n\nAssume the following well-tested facts and definitions:\n- The TD error is given by $\\delta_{t} = r_{t} + \\gamma V_{t+1} - V_{t}$, where $r_{t}$ is the obtained reward at time $t$, $V_{t}$ is the current state value estimate, $V_{t+1}$ is the next-state value estimate, and $\\gamma$ is the discount factor with $0 < \\gamma \\leq 1$.\n- For a terminal reward consumption event, $V_{t+1} = 0$, so $\\delta_{t} = r_{t} - V_{t}$.\n- Phasic dopamine transient sign mirrors the sign of $\\delta_{t}$: positive for $\\delta_{t} > 0$, negative for $\\delta_{t} < 0$, and approximately null for $\\delta_{t} \\approx 0$.\n\nAn animal trained to associate a drug-paired cue with reward undergoes a test session of $5$ trials. At the consumption time in each trial, the predicted value $V_{t}$ (dimensionless, inferred from neural activity) and the obtained reward $r_{t}$ (dimensionless, scaled to expected magnitude) are:\n\n- Trial $t=1$: $V_{1} = 0.10$, $r_{1} = 1.00$.\n- Trial $t=2$: $V_{2} = 0.50$, $r_{2} = 1.00$.\n- Trial $t=3$: $V_{3} = 0.80$, $r_{3} = 1.00$.\n- Trial $t=4$ (reward omission): $V_{4} = 0.90$, $r_{4} = 0.00$.\n- Trial $t=5$ (unexpected reward delivery, no predictive cue): $V_{5} = 0.00$, $r_{5} = 1.20$.\n\nLet the discount factor be $\\gamma = 0.98$. Use the terminal-event property to compute $\\delta_{t}$ for each trial.\n\nThen, predict the sign of the dopamine transient for the reward omission (trial $4$) and the unexpected reward delivery (trial $5$). Encode your sign predictions numerically as $-1$ for negative, $0$ for null, and $+1$ for positive.\n\nReport your final answer as a single row matrix in the order: $\\delta_{1}, \\delta_{2}, \\delta_{3}, \\delta_{4}, \\delta_{5}, s_{\\text{omission}}, s_{\\text{unexpected}}$. Express all entries as exact decimals (dimensionless). No rounding is required.", "solution": "The problem requires the calculation of the Temporal Difference (TD) error, $\\delta_{t}$, for a series of five trials in a Pavlovian conditioning experiment. The general formula for the TD error is given as:\n$$\n\\delta_{t} = r_{t} + \\gamma V_{t+1} - V_{t}\n$$\nHere, $r_{t}$ is the reward obtained at time $t$, $V_{t}$ is the estimated value of the current state, $V_{t+1}$ is the estimated value of the subsequent state, and $\\gamma$ is the discount factor, given as $\\gamma = 0.98$.\n\nA critical piece of information is that the reward consumption event is terminal within each trial. In the context of this model, a terminal state is one from which no further transitions or rewards can occur, and its value is defined to be zero. Therefore, the value of the next state, $V_{t+1}$, is zero for each of the specified trials.\n$$\nV_{t+1} = 0\n$$\nSubstituting this condition into the general TD error equation simplifies it significantly:\n$$\n\\delta_{t} = r_{t} + \\gamma (0) - V_{t} = r_{t} - V_{t}\n$$\nThis simplified formula, $\\delta_{t} = r_{t} - V_{t}$, will be used for all calculations. The provided discount factor $\\gamma = 0.98$ is extraneous to the calculation under the terminal-event assumption.\n\nWe now compute $\\delta_{t}$ for each of the five trials using the provided data for the predicted value $V_{t}$ and the obtained reward $r_{t}$.\n\nFor trial $t=1$:\n$V_{1} = 0.10$, $r_{1} = 1.00$.\n$$\n\\delta_{1} = r_{1} - V_{1} = 1.00 - 0.10 = 0.90\n$$\n\nFor trial $t=2$:\n$V_{2} = 0.50$, $r_{2} = 1.00$.\n$$\n\\delta_{2} = r_{2} - V_{2} = 1.00 - 0.50 = 0.50\n$$\n\nFor trial $t=3$:\n$V_{3} = 0.80$, $r_{3} = 1.00$.\n$$\n\\delta_{3} = r_{3} - V_{3} = 1.00 - 0.80 = 0.20\n$$\n\nFor trial $t=4$ (reward omission):\n$V_{4} = 0.90$, $r_{4} = 0.00$.\n$$\n\\delta_{4} = r_{4} - V_{4} = 0.00 - 0.90 = -0.90\n$$\n\nFor trial $t=5$ (unexpected reward):\n$V_{5} = 0.00$, $r_{5} = 1.20$.\n$$\n\\delta_{5} = r_{5} - V_{5} = 1.20 - 0.00 = 1.20\n$$\n\nNext, we must predict the sign of the phasic dopamine transient for trial $4$ and trial $5$. The problem states that the sign of the dopamine transient mirrors the sign of $\\delta_{t}$. The signs are to be encoded numerically as $+1$ for positive ($\\delta_{t} > 0$), $-1$ for negative ($\\delta_{t} < 0$), and $0$ for null ($\\delta_{t} \\approx 0$).\n\nFor the reward omission (trial $4$), the calculated TD error is $\\delta_{4} = -0.90$. Since $\\delta_{4} < 0$, the dopamine transient is predicted to be negative. The corresponding numerical code is $s_{\\text{omission}} = -1$.\n\nFor the unexpected reward delivery (trial $5$), the calculated TD error is $\\delta_{5} = 1.20$. Since $\\delta_{5} > 0$, the dopamine transient is predicted to be positive. The corresponding numerical code is $s_{\\text{unexpected}} = 1$.\n\nThe final answer must be reported as a single row matrix containing the values in the order: $\\delta_{1}, \\delta_{2}, \\delta_{3}, \\delta_{4}, \\delta_{5}, s_{\\text{omission}}, s_{\\text{unexpected}}$.\nThe resulting vector is:\n$$\n\\begin{pmatrix} 0.90 & 0.50 & 0.20 & -0.90 & 1.20 & -1 & 1 \\end{pmatrix}\n$$", "answer": "$$\n\\boxed{\\begin{pmatrix} 0.90 & 0.50 & 0.20 & -0.90 & 1.20 & -1 & 1 \\end{pmatrix}}\n$$", "id": "4502357"}, {"introduction": "The powerful learning signals driven by drugs of abuse leave a lasting trace on the brain's circuitry in the form of synaptic plasticity. A key cellular hallmark of this plasticity in the nucleus accumbens is the strengthening of excitatory synapses, often measured as an increase in the ratio of currents mediated by AMPA and NMDA receptors. This hands-on practice [@problem_id:4502346] delves into the biophysical underpinnings of this phenomenon, challenging you to connect macroscopic changes in the AMPA/NMDA ratio to the insertion of specific, inwardly-rectifying AMPA receptor subtypes, providing insight into the cellular mechanisms that consolidate addiction-related memories.", "problem": "A central feature of drug-evoked synaptic plasticity in the mesolimbic pathway is a rapid increase in the ratio of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) to N-methyl-D-aspartate receptor (NMDAR) synaptic current, often accompanied by insertion of GluA2-lacking AMPARs that exhibit inward rectification due to cytoplasmic polyamine block. Consider whole-cell voltage-clamp recordings from accumbal medium spiny neurons where AMPAR-mediated excitatory postsynaptic current (EPSC) is measured at a holding potential $V=-60 \\,\\mathrm{mV}$ and NMDAR-mediated EPSC is measured at $V=+40 \\,\\mathrm{mV}$ after $\\mathrm{Mg}^{2+}$ unblock. The baseline AMPA/NMDA ratio is $0.5$ and increases to $1.2$ after an acute drug exposure. Assume the following:\n\n- The AMPAR reversal potential is $E_{\\mathrm{rev,AMPA}} \\approx 0 \\,\\mathrm{mV}$, and for GluA2-containing AMPARs, the current-voltage relation is linear, $I_{\\mathrm{AMPA,lin}}(V) = g_{\\mathrm{lin}}(V - E_{\\mathrm{rev,AMPA}})$.\n- GluA2-lacking AMPARs are inwardly rectifying due to open-channel block by polyamines, modeled as $I_{\\mathrm{AMPA,rect}}(V) = g_{\\mathrm{rect}}(V - E_{\\mathrm{rev,AMPA}})\\,\\phi(V)$ with $\\phi(-60 \\,\\mathrm{mV}) = 1$ and $\\phi(+40 \\,\\mathrm{mV}) = b$, where $b=0.1$ is the outward suppression factor at positive potentials under standard intracellular spermine conditions.\n- The drug does not alter NMDAR current and does not change the conductance of pre-existing GluA2-containing AMPARs; the increase in AMPA/NMDA ratio from $0.5$ to $1.2$ is entirely attributable to insertion of GluA2-lacking AMPARs at $40\\%$ of synapses, adding to the AMPAR current at those synapses. Stimulation recruits the full synaptic population, so measured currents reflect the sum over all synapses.\n\nDefine the rectification index as $RI = \\frac{|I_{\\mathrm{AMPA}}(-60 \\,\\mathrm{mV})|}{|I_{\\mathrm{AMPA}}(+40 \\,\\mathrm{mV})|}$. Using the above biophysical definitions and assumptions:\n\n1. Compute the fold-change in the AMPA/NMDA ratio.\n2. Predict the change in rectification index, $\\Delta RI = RI_{\\mathrm{drug}} - RI_{\\mathrm{baseline}}$, resulting from the insertion of GluA2-lacking AMPARs.\n\nExpress your answers as dimensionless numbers. Round your answers to four significant figures.", "solution": "The problem requires the calculation of two quantities related to synaptic plasticity: the fold-change in the AMPA/NMDA ratio and the change in the AMPAR rectification index after a simulated drug exposure.\n\nThe solution is divided into two parts, corresponding to the two questions asked.\n\nPart 1: Compute the fold-change in the AMPA/NMDA ratio.\n\nThe AMPA/NMDA ratio is defined as the ratio of the magnitude of the AMPAR-mediated excitatory postsynaptic current (EPSC) at a holding potential of $V=-60 \\,\\mathrm{mV}$ to the NMDAR-mediated EPSC at $V=+40 \\,\\mathrm{mV}$.\n\nLet $R_{\\mathrm{baseline}}$ be the baseline AMPA/NMDA ratio and $R_{\\mathrm{drug}}$ be the ratio after drug exposure.\nThe problem provides the following values:\n$R_{\\mathrm{baseline}} = 0.5$\n$R_{\\mathrm{drug}} = 1.2$\n\nThe fold-change is the ratio of the post-drug value to the baseline value.\n$$\n\\text{Fold-change} = \\frac{R_{\\mathrm{drug}}}{R_{\\mathrm{baseline}}}\n$$\nSubstituting the given values:\n$$\n\\text{Fold-change} = \\frac{1.2}{0.5} = 2.4\n$$\nRounding to four significant figures, the fold-change is $2.400$.\n\nPart 2: Predict the change in rectification index, $\\Delta RI = RI_{\\mathrm{drug}} - RI_{\\mathrm{baseline}}$.\n\nThe rectification index ($RI$) is defined as:\n$$\nRI = \\frac{|I_{\\mathrm{AMPA}}(-60 \\,\\mathrm{mV})|}{|I_{\\mathrm{AMPA}}(+40 \\,\\mathrm{mV})|}\n$$\nWe need to calculate the $RI$ for both the baseline and post-drug conditions.\n\nStep 2a: Calculate $RI_{\\mathrm{baseline}}$.\nIn the baseline state, all AMPA receptors are of the GluA2-containing type, which have a linear current-voltage ($I$-$V$) relationship. The total current is given by:\n$$\nI_{\\mathrm{AMPA,baseline}}(V) = G_{\\mathrm{lin,total}}(V - E_{\\mathrm{rev,AMPA}})\n$$\nwhere $G_{\\mathrm{lin,total}}$ is the total conductance of all baseline AMPA receptors. The reversal potential is given as $E_{\\mathrm{rev,AMPA}} = 0 \\,\\mathrm{mV}$.\nSo, $I_{\\mathrm{AMPA,baseline}}(V) = G_{\\mathrm{lin,total}} \\cdot V$.\n\nThe currents at the specified voltages are:\n$$\nI_{\\mathrm{AMPA,baseline}}(-60 \\,\\mathrm{mV}) = G_{\\mathrm{lin,total}} \\cdot (-60)\n$$\n$$\nI_{\\mathrm{AMPA,baseline}}(+40 \\,\\mathrm{mV}) = G_{\\mathrm{lin,total}} \\cdot (40)\n$$\nNow we compute the baseline rectification index, $RI_{\\mathrm{baseline}}$:\n$$\nRI_{\\mathrm{baseline}} = \\frac{|G_{\\mathrm{lin,total}} \\cdot (-60)|}{|G_{\\mathrm{lin,total}} \\cdot (40)|} = \\frac{60 \\cdot G_{\\mathrm{lin,total}}}{40 \\cdot G_{\\mathrm{lin,total}}} = \\frac{60}{40} = 1.5\n$$\n\nStep 2b: Calculate $RI_{\\mathrm{drug}}$.\nAfter the drug exposure, GluA2-lacking, inwardly rectifying AMPARs are inserted. The total AMPAR current, $I_{\\mathrm{AMPA,drug}}(V)$, is the sum of the current from the pre-existing linear receptors and the newly inserted rectifying receptors. The conductance of the pre-existing receptors is unchanged.\n$$\nI_{\\mathrm{AMPA,drug}}(V) = I_{\\mathrm{AMPA,lin}}(V) + I_{\\mathrm{AMPA,rect}}(V)\n$$\nThe linear component is $I_{\\mathrm{AMPA,lin}}(V) = G_{\\mathrm{lin,total}} \\cdot V$.\nThe rectifying component is $I_{\\mathrm{AMPA,rect}}(V) = G_{\\mathrm{rect,total}}(V - E_{\\mathrm{rev,AMPA}})\\phi(V) = G_{\\mathrm{rect,total}} \\cdot V \\cdot \\phi(V)$, where $G_{\\mathrm{rect,total}}$ is the total conductance of the newly inserted receptors.\n\nFirst, we must determine the relationship between $G_{\\mathrm{lin,total}}$ and $G_{\\mathrm{rect,total}}$. We use the AMPA/NMDA ratio data for this. Let $I_{\\mathrm{N}} = |I_{\\mathrm{NMDAR}}(+40 \\,\\mathrm{mV})|$ be the magnitude of the NMDAR current, which is constant.\n\nThe baseline AMPA/NMDA ratio is:\n$$\nR_{\\mathrm{baseline}} = \\frac{|I_{\\mathrm{AMPA,baseline}}(-60 \\,\\mathrm{mV})|}{I_{\\mathrm{N}}} = \\frac{|G_{\\mathrm{lin,total}} \\cdot (-60)|}{I_{\\mathrm{N}}} = \\frac{60 \\cdot G_{\\mathrm{lin,total}}}{I_{\\mathrm{N}}} = 0.5\n$$\nThe post-drug AMPA/NMDA ratio is determined by the total current at $V=-60 \\,\\mathrm{mV}$. At this potential, the polyamine block factor is $\\phi(-60 \\,\\mathrm{mV}) = 1$.\n$$\nI_{\\mathrm{AMPA,drug}}(-60 \\,\\mathrm{mV}) = G_{\\mathrm{lin,total}} \\cdot (-60) + G_{\\mathrm{rect,total}} \\cdot (-60) \\cdot \\phi(-60) = -60(G_{\\mathrm{lin,total}} + G_{\\mathrm{rect,total}})\n$$\nSo, the post-drug ratio is:\n$$\nR_{\\mathrm{drug}} = \\frac{|I_{\\mathrm{AMPA,drug}}(-60 \\,\\mathrm{mV})|}{I_{\\mathrm{N}}} = \\frac{60(G_{\\mathrm{lin,total}} + G_{\\mathrm{rect,total}})}{I_{\\mathrm{N}}} = 1.2\n$$\nWe can rewrite this as:\n$$\n\\frac{60 \\cdot G_{\\mathrm{lin,total}}}{I_{\\mathrm{N}}} + \\frac{60 \\cdot G_{\\mathrm{rect,total}}}{I_{\\mathrm{N}}} = 1.2\n$$\nSubstituting $R_{\\mathrm{baseline}} = \\frac{60 \\cdot G_{\\mathrm{lin,total}}}{I_{\\mathrm{N}}} = 0.5$:\n$$\n0.5 + \\frac{60 \\cdot G_{\\mathrm{rect,total}}}{I_{\\mathrm{N}}} = 1.2 \\implies \\frac{60 \\cdot G_{\\mathrm{rect,total}}}{I_{\\mathrm{N}}} = 0.7\n$$\nNow we have two expressions:\n$$\n60 \\cdot G_{\\mathrm{lin,total}} = 0.5 \\cdot I_{\\mathrm{N}}\n$$\n$$\n60 \\cdot G_{\\mathrm{rect,total}} = 0.7 \\cdot I_{\\mathrm{N}}\n$$\nDividing the second by the first gives the ratio of conductances:\n$$\n\\frac{G_{\\mathrm{rect,total}}}{G_{\\mathrm{lin,total}}} = \\frac{0.7}{0.5} = 1.4\n$$\nThus, $G_{\\mathrm{rect,total}} = 1.4 \\cdot G_{\\mathrm{lin,total}}$.\n\nNow we can compute $RI_{\\mathrm{drug}}$. We need the total current at $V=+40 \\,\\mathrm{mV}$. The polyamine block factor at this voltage is $\\phi(+40 \\,\\mathrm{mV}) = b = 0.1$.\n$$\nI_{\\mathrm{AMPA,drug}}(+40 \\,\\mathrm{mV}) = I_{\\mathrm{AMPA,lin}}(+40) + I_{\\mathrm{AMPA,rect}}(+40)\n$$\n$$\nI_{\\mathrm{AMPA,drug}}(+40 \\,\\mathrm{mV}) = G_{\\mathrm{lin,total}} \\cdot (40) + G_{\\mathrm{rect,total}} \\cdot (40) \\cdot \\phi(+40)\n$$\n$$\nI_{\\mathrm{AMPA,drug}}(+40 \\,\\mathrm{mV}) = 40 \\cdot G_{\\mathrm{lin,total}} + 40 \\cdot G_{\\mathrm{rect,total}} \\cdot b = 40(G_{\\mathrm{lin,total}} + b \\cdot G_{\\mathrm{rect,total}})\n$$\nWe already found $|I_{\\mathrm{AMPA,drug}}(-60 \\,\\mathrm{mV})| = 60(G_{\\mathrm{lin,total}} + G_{\\mathrm{rect,total}})$.\nThe drug-state rectification index is:\n$$\nRI_{\\mathrm{drug}} = \\frac{|I_{\\mathrm{AMPA,drug}}(-60 \\,\\mathrm{mV})|}{|I_{\\mathrm{AMPA,drug}}(+40 \\,\\mathrm{mV})|} = \\frac{60(G_{\\mathrm{lin,total}} + G_{\\mathrm{rect,total}})}{40(G_{\\mathrm{lin,total}} + b \\cdot G_{\\mathrm{rect,total}})}\n$$\nSubstitute $G_{\\mathrm{rect,total}} = 1.4 \\cdot G_{\\mathrm{lin,total}}$:\n$$\nRI_{\\mathrm{drug}} = \\frac{60(G_{\\mathrm{lin,total}} + 1.4 \\cdot G_{\\mathrm{lin,total}})}{40(G_{\\mathrm{lin,total}} + b \\cdot (1.4 \\cdot G_{\\mathrm{lin,total}}))} = \\frac{60 \\cdot G_{\\mathrm{lin,total}}(1 + 1.4)}{40 \\cdot G_{\\mathrm{lin,total}}(1 + 1.4 \\cdot b)}\n$$\nThe $G_{\\mathrm{lin,total}}$ term cancels out. Now substitute $b=0.1$:\n$$\nRI_{\\mathrm{drug}} = \\frac{60(2.4)}{40(1 + 1.4 \\cdot 0.1)} = \\frac{144}{40(1 + 0.14)} = \\frac{144}{40(1.14)} = \\frac{144}{45.6}\n$$\n$$\nRI_{\\mathrm{drug}} \\approx 3.15789...\n$$\n\nStep 2c: Calculate the change in rectification index, $\\Delta RI$.\n$$\n\\Delta RI = RI_{\\mathrm{drug}} - RI_{\\mathrm{baseline}}\n$$\n$$\n\\Delta RI = 3.15789... - 1.5 = 1.65789...\n$$\nRounding to four significant figures, $\\Delta RI = 1.658$.\n\nFinal answers:\n1. The fold-change in the AMPA/NMDA ratio is $2.400$.\n2. The change in the rectification index, $\\Delta RI$, is $1.658$.", "answer": "$$\n\\boxed{\\begin{pmatrix} 2.400 & 1.658 \\end{pmatrix}}\n$$", "id": "4502346"}]}